These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7412536)

  • 1. [Duodenogastric reflux and therapy with bromoprid].
    Hennig FF
    Med Welt; 1980 Apr; 31(15):566-8. PubMed ID: 7412536
    [No Abstract]   [Full Text] [Related]  

  • 2. [Stimulation of esophageal motility with bromoprid, domperidon and metoclopramide. Therapy of esophageal reflux disease].
    Lux G; Engel H; Rösch W
    Fortschr Med; 1980 May; 98(18):708-11. PubMed ID: 7390390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyloric incompetence in patients with symptomatic gastroesophageal reflux.
    Kaye MD; Showalter JP
    J Lab Clin Med; 1974 Feb; 83(2):198-206. PubMed ID: 4810950
    [No Abstract]   [Full Text] [Related]  

  • 4. [Manometric evaluation of drug therapy in gastroesophageal reflux].
    Caro Pérez F; Sancho Fornos S; García Fresquet JV; Valero Rustarazo J
    Rev Esp Enferm Apar Dig; 1983 Mar; 63(3):256-65. PubMed ID: 6867428
    [No Abstract]   [Full Text] [Related]  

  • 5. Bile reflux, gastric secretion, and heartburn.
    Gillison EW; Nyhus LM
    Br J Surg; 1971 Nov; 58(11):864. PubMed ID: 5124881
    [No Abstract]   [Full Text] [Related]  

  • 6. Problems in duodenogastric reflux assessment, using bile acid and lysolecithin measurement.
    Begemann F; Schumpelick V
    Scand J Gastroenterol Suppl; 1981; 67():51-3. PubMed ID: 6941424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cholecystectomy on bile reflux. An experimental study.
    Demetriades D
    S Afr Med J; 1985 Aug; 68(4):235-8. PubMed ID: 4035477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of Helicobacter pylori infection and duodenogastric reflux on the histology of gastric mucosa in peptic ulcers].
    Kopański Z; Cienciała A; Brandys J; Zastepa P; Micherdziński J; Witkowska B; Czajecki K
    Folia Med Cracov; 1996; 37(1-2):3-14. PubMed ID: 9312525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of secretin on duodenogastric reflux in vagotomised dogs.
    Demetriades D; Beale EO
    S Afr Med J; 1987 Oct; 72(7):499-500. PubMed ID: 3660159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantification of bile acids and lysolecithin in gastric and duodenal ulcers].
    Calvo C; Ortiz P; Milos C
    Rev Med Chil; 1983 Mar; 111(3):247-50. PubMed ID: 6648104
    [No Abstract]   [Full Text] [Related]  

  • 11. Duodenogastric reflux and gastric mucosal polyamines in the non-operated stomach and in the gastric remnant after Billroth II gastric resection. A role in gastric carcinogenesis?
    Lorusso D; Linsalata M; Pezzolla F; Berloco P; Osella AR; Guerra V; Di Leo A; Demma I
    Anticancer Res; 2000; 20(3B):2197-201. PubMed ID: 10928177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quantification in human gastric juice of duodenogastric reflux by sodium output and by bile-labelling using indocyanine green.
    Fiddian-Green RG; Parkin JV; Faber RG; Russell RC; Whitfield PF; Hobsley M
    Klin Wochenschr; 1979 Aug; 57(16):815-24. PubMed ID: 502348
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of cholagogues on gastric secretion in peptic ulcer].
    Saakian AG; Moiseeva NV; Masliĭ VV
    Vrach Delo; 1982 Jul; (7):48-51. PubMed ID: 7135904
    [No Abstract]   [Full Text] [Related]  

  • 14. [Method of determining lysophosphatidylcholine (lysolecithin) in gastric juice].
    Pozdniakov VS; Kuzin NM; Liadov KV
    Lab Delo; 1987; (11):839-41. PubMed ID: 2448531
    [No Abstract]   [Full Text] [Related]  

  • 15. Lysolecithin: a factor in the pathogenesis of gastric ulceration?
    Johnson AG
    Gut; 1972 Oct; 13(10):843. PubMed ID: 5087088
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cinitapride in the treatment of gastroesophageal reflux. Comparative study with metoclopramide and placebo].
    Surós A; Adell F; De Novoa V; Castellarnau J; Diosdado D; Carrasquer J; Merelló J
    Rev Med Univ Navarra; 1992; 37(1):18-23. PubMed ID: 1626164
    [No Abstract]   [Full Text] [Related]  

  • 17. A controlled trail of metoclopramide in reflux oesophagitis.
    Paull A; Kerr A; Grant AK
    Med J Aust; 1974 Oct; 2(17):627-9. PubMed ID: 4614025
    [No Abstract]   [Full Text] [Related]  

  • 18. [Functional behavior patterns of the pylorus in duodeno-gastric reflux].
    Koelsch KA; Kühne C; Zemlin C
    Z Gesamte Inn Med; 1979 Sep; 34(17):227-9. PubMed ID: 539011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Duodenogastric reflux: validation study of its endoscopic visualization].
    Ortiz P; Santibáñez G; Briones E; Marín V; Palma A
    Rev Med Chil; 1998 Mar; 126(3):279-83. PubMed ID: 9674297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroduodenal motility patterns associated with pyloric reflux.
    Johnson AG
    Br J Surg; 1971 Nov; 58(11):864-5. PubMed ID: 5124882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.